The EuroXanth COST Action had its 1st Workshop at Beamedex® in Paris-Orsay, France, on April 3, 2018. The SME Beamedex® has the primary objective to invent, develop and market products for public health research services. These products use the Luminex® platform, a high-throughput suspension chip bead-based molecular typing technology that improves multiplexing and lowers costs. Beamedex® also provides training, customized services and bioinformatical support to improve knowledge based on previous high-throughput data production.
The workshop welcomed participants from six countries (see below) and served as a platform to discuss theoretical and practical aspects of CRISPR typing and its application to plant-pathogenic xanthomonads, which is of specific interest to Working Group WG1 (Diagnostics & Diversity – Population Structure). Representatives of all four Working Groups met to evaluate the potential of this approach to achieve the EuroXanth Objectives and its tangible Deliverables.
List of Participants
|CATARA, Vittoria||Vice Chair||IT||WG3|
|COSTA, Joana||WG1 Leader||PT||WG1|
|DREO, Tanja||MC Member||SI||WG1|
|POTHIER, Joël F.||WG2 Leader||CH||WG2|
|STOYANOVA, Mariya||MC Member||BG||WG4|
The Minutes of the Workshop are available for download: CRISPR-Workshop Paris 2018 Minutes.